Actively Recruiting
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
Led by Hackensack Meridian Health · Updated on 2026-02-10
86
Participants Needed
1
Research Sites
118 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.
CONDITIONS
Official Title
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult emergency department patients younger than 65 years old
- Presenting with one or more of the following: flank pain, back pain, abdominal pain, lower quadrant pain, or pelvic pain
- Pain score of 4 or greater on a 0-10 numeric rating scale
- Planned treatment with intravenous ketorolac
You will not qualify if you...
- Allergy to ketorolac
- Pregnancy
- Received analgesic medication within 4 hours before ketorolac administration
- Known or reported history of renal insufficiency
- Body weight less than 50 kg
- Age older than 65 years
- Cannot read or write Spanish or English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hackensack Univarsity medical Center
Hackensack, New Jersey, United States, 07601
Actively Recruiting
Research Team
B
Biren Bhatt, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here